Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03695783 · ClinicalTrials.gov registry record · NA
The IBD&me Randomized Controlled Trial
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT03695783 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 152 participants.
The verdict
NCT03695783, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
Navigating the risk-benefit profiles of the various biologic options approved for inflammatory bowel disease (IBD) can be challenging for patients who are considering biologic therapies as a treatment option. Thus, there is a need for simple and efficient tools that elicit individual preferences and support the patient-provider interaction. The principal objective of this study is to assess the impact of an online decision aid called IBD\&me on patient perceptions of shared-decision making as compared to a standardized education arm.
Interventions
- OTHER Online decision aid called IBD&me
- OTHER Standardized educational material
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2021-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03695783
The ClinicalTrials.gov registry entry for NCT03695783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Online decision aid called IBD&me is the first listed.
NCT03695783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03695783 about?
NCT03695783 is a clinical study titled "The IBD&me Randomized Controlled Trial". Navigating the risk-benefit profiles of the various biologic options approved for inflammatory bowel disease (IBD) can be challenging for patients who are considering biologic therapies as a treatment option. Thus, there is a need for simple and efficient tools that elicit individual preferences and...
What is the current status of trial NCT03695783?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2019-03-06. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT03695783?
The interventions under investigation include: Online decision aid called IBD&me (OTHER), Standardized educational material (OTHER).
Who is sponsoring clinical trial NCT03695783?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.